Suitability of Tartrate-Resistant Acid Phosphatase Type 5b as a Screening Marker for Bone Mineral Density in Community-Dwelling Elderly Individuals

Suitability of Tartrate-Resistant Acid Phosphatase Type 5b as a Screening Marker for Bone Mineral Density in Community-Dwelling Elderly Individuals
复制标题

DOI:
10.1620/tjem.224.105
复制
发表时间:
2011-06-01
影响因子:
2.2
通讯作者:
Takamura, Noboru
Takamura, Noboru
中科院分区:
医学4区
文献类型:
--
作者:
Irie, Sumiko;Hayashida, Naomi;Takamura, Noboru

文献摘要

被引文献

相似文献

Osteoporosis is a common disorder in aging populations that imposes considerable health problems. Tartrate-resistant acid phosphatase type 5b (TRAP-5b) is derived from osteoclasts, and is involved in normal bone homeostasis. Recently, a novel assay system for TRAP-5b, the fragments absorbed immunocapture enzymatic assay method, has been developed. To evaluate the suitability of TRAP-5b as a screening marker for bone mineral density (BMD), we explored the correlations between serum TRAP-5b concentrations and laboratory findings, body mass index, or BMD in 462 community-dwelling elderly individuals (249 men and 213 women, age 73.4 +/- 6.5 years) who participated in a regular medical screening program. By multivariate linear regression analysis adjusted for confounding factors, TRAP-5b was significantly correlated with body mass index (beta = -0.005, p = 0.043), alkaline phosphatase, a marker for osteoid formation and calcification (beta = 0.001, p < 0.001), and triglyceride (beta = -0.097, p = 0.016) in men, and with body mass index (beta = -0.009, p = 0.025), alkaline phosphatase (beta = 0.001, p < 0.001), calcium (beta = -0.059, p = 0.039), and bone trabecular area ratio (beta = -0.47, p = 0.025) in women. In conclusion, the elevated serum level of TRAP-5b is independently correlated with the decreased BMD in women, but not in men. Because measurement of TRAP-5b is not affected by food intake, and blood samples can be collected at any time of the day, we suggest the suitability of serum TRAP-5b as a simple marker for the evaluation of BMD in women.